Autoimmune hepatitis in Italy, changing epidemiology or increased awareness? Evidence from a 40-years referral-centre study

M. Ferronato,M. Lenzi,L. Muratori

DOI: https://doi.org/10.1016/j.dld.2024.01.034

IF: 5.165

2024-02-01

Digestive and Liver Disease

Abstract:Background Autoimmune hepatitis (AIH) is a chronic inflammatory disease of the liver with clinically heterogeneous presentations, ranging from asymptomatic detection of altered liver function tests to acute icteric hepatitis. Aim To describe the changing presentation of AIH, its clinical and immunological modification and prognosis during the last 40 years in Italy. Methods Single-centre, tertiary-care retrospective study on 507 consecutive Italian patients with AIH. The cohort has been divided in four subgroups according to the year of diagnosis: 1981-1990, 1991-2000, 2001-2010 and 2011-2020. Clinical, laboratory, histological and immunological features at diagnosis have been collected; response to treatment and clinical outcomes have been assessed. Acute presentation is defined as transaminase > 10-fold the upper limit and/or a bilirubin >5 mg/dL. Complete response is defined as normalization of transaminases and IgG after 12 months of standard treatment. Clinical progression is defined as development of cirrhosis in non-cirrhotic patients and hepatic decompensation or hepatocellular carcinoma in compensated cirrhosis. Results Median age at diagnosis increased across decades (24, 31, 39, 52 years, p<0.001). Female sex remained predominant (p=0.487). Acute onset became the most common presentation (39.6%, 44.4%, 47.7%, 59.5%, p=0.019), while cirrhosis at diagnosis became less frequent (36.5%, 16.3%, 10.8%, 8.7%, p<0.001). Complete response rates rose (11.1%, 49.4%, 72.7%, 76.2%, p<0.001) and clinical progression during follow-up decreased (54.3%, 29.9%, 16.9%, 11.2%, p<0.001). Anti-nuclear antibodies positivity increased (40.7%, 52.0%, 73.7%, 79.3%, p <0.001), while IgG levels/upper limit progressively decreased (1.546, 1.515, 1.252, 1.120, p <0.001). Liver-related death and liver transplantation reduced (17.1%, 9.2%, 2.5%, 2.1%, p<0.001). Conclusions In the new millennium the most common onset of AIH in Italy is acute hepatitis in a 50-year or older female non-cirrhotic patient, very likely to respond completely to standard treatment and less at risk to progress to cirrhosis and its complications.

gastroenterology & hepatology